These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis. Asensio C; Cettour-Rose P; Theander-Carrillo C; Rohner-Jeanrenaud F; Muzzin P Endocrinology; 2004 May; 145(5):2206-13. PubMed ID: 14962997 [TBL] [Abstract][Full Text] [Related]
3. Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia. Lee JH; Bullen JW; Stoyneva VL; Mantzoros CS Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E625-32. PubMed ID: 15522996 [TBL] [Abstract][Full Text] [Related]
4. Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA. Makimura H; Mizuno TM; Bergen H; Mobbs CV Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1266-71. PubMed ID: 12388167 [TBL] [Abstract][Full Text] [Related]
5. Pituitary resistin gene expression: effects of age, gender and obesity. Morash BA; Ur E; Wiesner G; Roy J; Wilkinson M Neuroendocrinology; 2004 Mar; 79(3):149-56. PubMed ID: 15103228 [TBL] [Abstract][Full Text] [Related]
6. Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice. Delporte ML; El Mkadem SA; Quisquater M; Brichard SM Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E446-53. PubMed ID: 15126241 [TBL] [Abstract][Full Text] [Related]
7. Conjugated linoleic acid deteriorates insulin resistance in obese/diabetic mice in association with decreased production of adiponectin and leptin. Ohashi A; Matsushita Y; Kimura K; Miyashita K; Saito M J Nutr Sci Vitaminol (Tokyo); 2004 Dec; 50(6):416-21. PubMed ID: 15895517 [TBL] [Abstract][Full Text] [Related]
8. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. Heilbronn LK; Rood J; Janderova L; Albu JB; Kelley DE; Ravussin E; Smith SR J Clin Endocrinol Metab; 2004 Apr; 89(4):1844-8. PubMed ID: 15070954 [TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and obesity: resistin, a hormone secreted by adipose tissue. Wolf G Nutr Rev; 2004 Oct; 62(10):389-94. PubMed ID: 15508908 [TBL] [Abstract][Full Text] [Related]
10. [Resistine--a new hormone secreted by adipose tissue (adipose tissue in insulin resistance)]. Kochan Z; Karbowska J Przegl Lek; 2003; 60(1):40-2. PubMed ID: 12884646 [TBL] [Abstract][Full Text] [Related]
11. The hormone resistin links obesity to diabetes. Steppan CM; Bailey ST; Bhat S; Brown EJ; Banerjee RR; Wright CM; Patel HR; Ahima RS; Lazar MA Nature; 2001 Jan; 409(6818):307-12. PubMed ID: 11201732 [TBL] [Abstract][Full Text] [Related]
12. Low resistin levels in adipose tissues and serum in high-fat fed mice and genetically obese mice: development of an ELISA system for quantification of resistin. Maebuchi M; Machidori M; Urade R; Ogawa T; Moriyama T Arch Biochem Biophys; 2003 Aug; 416(2):164-70. PubMed ID: 12893293 [TBL] [Abstract][Full Text] [Related]
13. [Reduced resistin levels in patients with type 2 diabetes mellitus]. Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723 [TBL] [Abstract][Full Text] [Related]
15. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. McTernan PG; Fisher FM; Valsamakis G; Chetty R; Harte A; McTernan CL; Clark PM; Smith SA; Barnett AH; Kumar S J Clin Endocrinol Metab; 2003 Dec; 88(12):6098-106. PubMed ID: 14671216 [TBL] [Abstract][Full Text] [Related]
16. Suppressing hyperinsulinemia prevents obesity but causes rapid onset of diabetes in leptin-deficient D'souza AM; Johnson JD; Clee SM; Kieffer TJ Mol Metab; 2016 Nov; 5(11):1103-1112. PubMed ID: 27818936 [TBL] [Abstract][Full Text] [Related]
17. Hypothalamic resistin immunoreactivity is reduced by obesity in the mouse: co-localization with alpha-melanostimulating hormone. Wilkinson M; Wilkinson D; Wiesner G; Morash B; Ur E Neuroendocrinology; 2005; 81(1):19-30. PubMed ID: 15809509 [TBL] [Abstract][Full Text] [Related]
18. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity. Watson E; Hahm S; Mizuno TM; Windsor J; Montgomery C; Scherer PE; Mobbs CV; Salton SR Endocrinology; 2005 Dec; 146(12):5151-63. PubMed ID: 16141392 [TBL] [Abstract][Full Text] [Related]
19. Resistin/ADSF/FIZZ3 in obesity and diabetes. Sul HS Trends Endocrinol Metab; 2004 Aug; 15(6):247-9. PubMed ID: 15358276 [TBL] [Abstract][Full Text] [Related]
20. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Asakawa A; Inui A; Kaga T; Katsuura G; Fujimiya M; Fujino MA; Kasuga M Gut; 2003 Jul; 52(7):947-52. PubMed ID: 12801949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]